MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$161,657K
Prepaid expenses and
other current assets
$9,498K
Other receivables
$186K
Total current assets
$171,341K
Operating right-of-use
asset
$5,052K
Other non-current
assets
$4,378K
Property and equipment,
net
$3,196K
Total assets
$183,967K
Accumulated deficit
-$279,628K
Total liabilities and
stockholders equity...
$183,967K
Total stockholders
equity (deficit)
-$21,035K
Additional
paid-in-capital
$258,592K
Common stock, 0.0001
par value...
$1K
Total liabilities
$205,002K
Long-term debt, net
$174,994K
Total current
liabilities
$26,512K
Non-current portion of
operating lease liability
$3,496K
Accrued expenses
$15,342K
Accounts payable
$8,762K
Current portion of
operating lease liability
$2,408K
Back
Back
Balance Sheet
source: myfinsight.com
Inhibrx Biosciences, Inc. (INBX)
Inhibrx Biosciences, Inc. (INBX)